OVARIAN CANCER RECURRENT

This adverse event was reported 814 times

These drugs are most commonly taken by patients reporting OVARIAN CANCER RECURRENT:

# Drug Count
0 NIRAPARIB 185
1 OLAPARIB 142
2 CARBOPLATIN 133
3 RUCAPARIB 119
4 PACLITAXEL 87
5 BEVACIZUMAB 80
6 GEMCITABINE HYDROCHLORIDE 49
7 GEMCITABINE 42
8 CISPLATIN 38
9 DOXORUBICIN HYDROCHLORIDE 23
See all common drugs associated with OVARIAN CANCER RECURRENT

OVARIAN CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE 1 0.0263
1 RUCAPARIB 119 0.0158
2 OLAPARIB 142 0.0147
3 NIRAPARIB 185 0.0126
4 CHERYLEE MD SENSITIVE SKIN CARE TRUELIPIDS DOUBLE ACTION BOO-BOO BUM 3 0.0075
5 PANTHENOL 1 0.0048
6 WHITE PETROLATUM 3 0.0041
7 TOPOTECAN 20 0.0041
8 POVIDONE IODINE 10% 2 0.0037
9 GLYCERINE 1 0.0030
See all drugs enriched for association with OVARIAN CANCER RECURRENT